Starting GLP-1 therapy represents a significant step in managing diabetes or obesity, and understanding what to anticipate helps ensure realistic expectations and optimal outcomes
Paying attention to how different foods make you feel can help refine choices
Moreover, these findings provide valuable insights for metabolic investigations, reinforcing retatrutides significance as a benchmark triple-agonist compound and offering a strong foundation for future studies in obesity and related metabolic disorders
CrossRef Harnessing Gut MicrobiomeBrainLiver Crosstalk: Novel Therapeutic Strategies for Metabolic DysfunctionAssociated Steatotic Liver Disease Xingtao Zhao, Ruolan Li, Jingdong Zhao, Ruiqi Sun, Shuo Zhang, Qiong Pan, Hongyan Lu, Jin Chai Medicine Bulletin .2025
Not a substitute for approved therapy